Ò©Îï·ÖÎö
ÍâÃÚÌåµ°°××éÖúÁ¦Î¢»·¾³Ï¸°ûÖرà³Ì
¼ä³äÖÊ»ùÖÊϸ°û(MSCs)ÊÇ×é³É¹ÇËè(BM)΢»·¾³µÄÖ÷Ҫϸ°ûÀàÐÍÖ®Ò»£¬¾ßÓзֻ¯µÄ¶à¹¦ÄÜÐÔ£¬²¢²ÎÓë²¢µ÷¿Ø°×Ѫ²¡Éú³¤ºÍÄÍÒ©ÐÔ¡£×î½üÓб¨µÀÏÔʾ°×Ѫ²¡»¼ÕßÀ´Ô´µÄMSCsµÄ»ùÒòÐͺͱíÐͻᷢÉú¸Ä±ä£¬±íÃ÷MSCs¿ÉÄܻᱻÖرà³Ì¡£
2022Äê3Ô£¬Õã½´óѧҽѧԺ³ÂìÇÑо¿Ô±¿ÎÌâ×é½ÒʾÁ˼±ÐÔËèÐÔ°×Ѫ²¡À´Ô´µÄ¼ä³äÖʸÉϸ°ûÇãÏòÓÚ·Ö»¯ÎªÖ¬·¾Ï¸°ûµÄ»úÖÆ£¬Ïà¹ØÑо¿³É¹ûÒÔ“Acute MyeloidLeukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities”ΪÌâ·¢±íÔÚAdv Sci £¨IF=16.806£©ÉÏ¡£
Ñо¿ÈËÔ±Ê×ÏÈÓÃÕý³£ºÍAMLÑÜÉúµÄÅàÑø»ùÅàÑøhMSCsϸ°û£¬ÓͺìȾɫ·¢ÏÖAMLÑÜÉúµÄÅàÑø»ù±íÏÖ³öÔöÇ¿MSCsµÄÖ¬·¾Éú³ÉºÍÑӳٵijɹǷֻ¯ÄÜÁ¦£¨Í¼1A£©¡£ËæºóAMLϸ°ûÓëhMSCs¹²ÅàÑø·¢ÏÖ£¬AMLϸ°û´Ù½øÕý³£hMSCs·Ö»¯³ÉÖ¬·¾Æ×ϵ²¢ÑÓ»º³É¹Ç·Ö»¯£¨Í¼1B£©¡£½øÒ»²½RNA-seq ·ÖÎö·¢ÏÖÌåÍâʵÑéÖÐÓëAML¹²ÅàÑøµÄMSCsÖлùÒò±í´ï·¢ÉúÏÔÖø±ä»¯£¬Ö÷Òª¸»¼¯ÔÚÌÇ´úлµÈϸ°û¹ý³ÌÉÏ£¨Í¼1C£©£¬²¢Í¨¹ý½øÒ»²½È·ÈÏÁËMSCµÄÌÇ´úлÉϵ÷£¨Í¼1D£©¡£
ͼ1 AMLϸ°ûÓëhMSCs¹²ÅàÑø´Ù½øhMSCs·Ö»¯ÎªÖ¬·¾Ï¸°ûÉϵ÷ÆäÌÇ´úл
ÍâÃÚÌåÒòÆäÔÚϸ°û¼äµÄͨѶ×÷Óñ»¹ã·ºÈÏÖª£¬Îª½øÒ»²½½âÊÍAMLϸ°ûÈçºÎÓ°ÏìMSCsµÄÐÐΪ£¬Ñо¿ÈËÔ±ÍƲâAMLϸ°û¿ÉÄÜÊÇͨ¹ýÍâÃÚÌåÓ°ÏìMSCsµÄ¡£Ï¸°û¹²ÅàÑøʵÑé·¢ÏÖ£¬AMLϸ°û·ÖÃÚµÄÍâÃÚÌåÄܹ»±»hMSCÉãÈ¡£¨Í¼2A£©²¢ÔöÇ¿MSCsµÄÖ¬·¾Éú³ÉºÍÑӳٵijɹǷֻ¯ÄÜÁ¦£¨Í¼2B£©¡£Í¨¹ýTMT¶¨Á¿µ°°×ÖÊ×éѧ·ÖÎö£¨k8¿·¢(Öйú)Ìṩ¼¼Êõ·þÎñ£©£¬Ñо¿ÈËÔ±ÔÚAML·ÖÃÚµÄÍâÃÚÌåÖй²¼ø¶¨ÁË710ÖÖµ°°×¡£ÕâЩµ°°×Ö÷ÒªÓëRNAת¼£¨Í¼2C£©¡¢ÌÇ´úл£¨Í¼2D£©µÈ¹¦ÄÜÃÜÇÐÏà¹Ø¡£ÍâÃÚÌ嶨Á¿µ°°××éÊý¾ÝÓëRNA-seqÖ¸ÏòÒ»Ö£¬¶¼ËµÃ÷ÓëAML¹²ÅàÑøµÄMSCsÖÐÌÇ´úл·¢ÉúÏÔÖø±ä»¯¡£×îÖÕͨ¹ýÉîÈëÑо¿±íÃ÷£¬AMLϸ°û¿Éͨ¹ý·ÖÃÚ¸»º¬ÌÇ´úлÏà¹Øµ°°×µÄÍâÃÚÌå¼ä½Óµ÷¿ØMSCsϸ°ûµÄÌÇ´úл£¬½ø¶øÒýÆðMSCsϸ°ûÖرà³ÌµÄ·¢Éú¡£
ͼ2 AMLϸ°û·ÖÃÚµÄÍâÃÚÌå±»hMSCsÉãÈ¡Ó°ÏìÆäÌÇ´úл
×îºó£¬ÎªÑéÖ¤MSCsϸ°ûÖرà³Ì´øÀ´µÄÌåÄÚÓ°Ï죬Ñо¿ÈËÔ±¾¹ýβ¾²Âö×¢ÉäAMLÑÜÉúµÄÍâÃÚÌåµ½°×Ѫ²¡Ð¡ÊóÌåÄÚ£¬·¢ÏÖСÊó´æ»îÂÊÏÔÖø½µµÍ£¬°×Ѫ²¡±íÐ͸ü¼ÓÃ÷ÏÔ£¨Í¼3A-3C£©¡£×ÛÉÏ£¬¸ÃÑо¿ÏÔʾAML·ÖÃÚµÄÍâÃÚÌåÖеĵ°°×ÖÊʹµÃMSCsÇãÏòÓÚ·Ö»¯³Éµ¼Ö¼²²¡½øÕ¹µÄÖ¬·¾Ï¸°û£¬±íÃ÷ÁË°×Ѫ²¡Óë΢»·¾³Ö®¼ä´æÔÚ¸´ÔÓµÄÏ໥×÷Óá£Í¬Ê±£¬¸ÃÑо¿Öз¢ÏÖµÄÍâÃÚÌåµ°°×¼°µ÷¿Ø»úÖÆҲΪѧ½ç̽Ë÷еÄÖÎÁÆAMLµÄÊÖ¶ÎÌṩÁË¿Æѧ»ù´¡¡£
ͼ3 AMLϸ°û·ÖÃÚµÄÍâÃÚÌåÌåÄÚ´Ù½ø°×Ѫ²¡·¢Éú
ÎÄÏ×ÔÎÄ£º Zhang L, Zhao Q, Cang H, et al. Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities. Adv Sci (Weinh). 2022 Mar 20:e2105811.
µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã
µç»°£º400-869-2936£¬021-33968791
ÓÊÏ䣺support@wayenbiotech.com
´«Õ棺021-33938792
QQ£º2120485725
Õ½ÂÔºÏ×÷
Õ½ÂÔºÏ×÷
| Full Moon | RayBiotech | CDI | IZON | Bio-Rad | R&D Systems | IsoPlexis | ÄÏÄ£ÉúÎï | Å·Ò×ÉúÎï | ÆäÃ÷ÐÅÏ¢ | ÃÀ¼ªÉúÎï | ÂóÌØ»æÆ× |
Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿·¢(Öйú)Ô´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£